These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 19955921

  • 1. Fasudil inhibits lysophosphatidic acid-induced invasiveness of human ovarian cancer cells.
    Ogata S, Morishige K, Sawada K, Hashimoto K, Mabuchi S, Kawase C, Ooyagi C, Sakata M, Kimura T.
    Int J Gynecol Cancer; 2009 Dec; 19(9):1473-80. PubMed ID: 19955921
    [Abstract] [Full Text] [Related]

  • 2. Lysophosphatidic acid induces focal adhesion assembly through Rho/Rho-associated kinase pathway in human ovarian cancer cells.
    Sawada K, Morishige Ki, Tahara M, Ikebuchi Y, Kawagishi R, Tasaka K, Murata Y.
    Gynecol Oncol; 2002 Dec; 87(3):252-9. PubMed ID: 12468322
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The Rho kinase inhibitor fasudil inhibits tumor progression in human and rat tumor models.
    Ying H, Biroc SL, Li WW, Alicke B, Xuan JA, Pagila R, Ohashi Y, Okada T, Kamata Y, Dinter H.
    Mol Cancer Ther; 2006 Sep; 5(9):2158-64. PubMed ID: 16985048
    [Abstract] [Full Text] [Related]

  • 7. Fasudil protects cultured N1E-115 cells against lysophosphatidic acid-induced neurite retraction through inhibition of Rho-kinase.
    Satoh S, Kawasaki K, Hitomi A, Ikegaki I, Asano T.
    Brain Res Bull; 2011 Feb 01; 84(2):174-7. PubMed ID: 21126559
    [Abstract] [Full Text] [Related]

  • 8. The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion.
    Jeong KJ, Park SY, Cho KH, Sohn JS, Lee J, Kim YK, Kang J, Park CG, Han JW, Lee HY.
    Oncogene; 2012 Sep 27; 31(39):4279-89. PubMed ID: 22249252
    [Abstract] [Full Text] [Related]

  • 9. Fasudil inhibits vascular endothelial growth factor-induced angiogenesis in vitro and in vivo.
    Yin L, Morishige K, Takahashi T, Hashimoto K, Ogata S, Tsutsumi S, Takata K, Ohta T, Kawagoe J, Takahashi K, Kurachi H.
    Mol Cancer Ther; 2007 May 27; 6(5):1517-25. PubMed ID: 17513600
    [Abstract] [Full Text] [Related]

  • 10. ROCK inhibition with Fasudil induces beta-catenin nuclear translocation and inhibits cell migration of MDA-MB 231 human breast cancer cells.
    Guerra FS, Oliveira RG, Fraga CAM, Mermelstein CDS, Fernandes PD.
    Sci Rep; 2017 Oct 20; 7(1):13723. PubMed ID: 29057980
    [Abstract] [Full Text] [Related]

  • 11. Effect of fasudil on growth, adhesion, invasion, and migration of 95D lung carcinoma cells in vitro.
    Yang X, Zhang Y, Wang S, Shi W.
    Can J Physiol Pharmacol; 2010 Sep 20; 88(9):874-9. PubMed ID: 20921973
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which are negatively involved in lysophosphatidic acid-induced cell invasion.
    Sengupta S, Kim KS, Berk MP, Oates R, Escobar P, Belinson J, Li W, Lindner DJ, Williams B, Xu Y.
    Oncogene; 2007 May 03; 26(20):2894-901. PubMed ID: 17130843
    [Abstract] [Full Text] [Related]

  • 15. The G12/13-RhoA signaling pathway contributes to efficient lysophosphatidic acid-stimulated cell migration.
    Bian D, Mahanivong C, Yu J, Frisch SM, Pan ZK, Ye RD, Huang S.
    Oncogene; 2006 Apr 06; 25(15):2234-44. PubMed ID: 16301993
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The Rho-kinase inhibitor inhibits proliferation and metastasis of small cell lung cancer.
    Yang X, Di J, Zhang Y, Zhang S, Lu J, Liu J, Shi W.
    Biomed Pharmacother; 2012 Apr 06; 66(3):221-7. PubMed ID: 22425182
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of the Rho/ROCK pathway enhances the efficacy of cisplatin through the blockage of hypoxia-inducible factor-1α in human ovarian cancer cells.
    Ohta T, Takahashi T, Shibuya T, Amita M, Henmi N, Takahashi K, Kurachi H.
    Cancer Biol Ther; 2012 Jan 01; 13(1):25-33. PubMed ID: 22336585
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The kinase inhibitor fasudil (HA-1077) reduces intimal hyperplasia through inhibiting migration and enhancing cell loss of vascular smooth muscle cells.
    Negoro N, Hoshiga M, Seto M, Kohbayashi E, Ii M, Fukui R, Shibata N, Nakakoji T, Nishiguchi F, Sasaki Y, Ishihara T, Ohsawa N.
    Biochem Biophys Res Commun; 1999 Aug 19; 262(1):211-5. PubMed ID: 10448094
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.